5 Grants
2019
Pragmatic randomised trial of High Or Standard PHosphAte Targets in End-stage kidney disease (The PHOSPHATE Study)
Badve, Sunil
National Health and Medical Research Council (NHMRC) (ID: 1162410), $1,748,534AUD, 2019 -- 2023
 
Treatment of cardiovascular disease with very low dose Rivaroxaban in Advanced Chronic Kidney disease (The TRACK Trial)
Badve, Sunil
National Health and Medical Research Council (NHMRC) (ID: 1162375), $5,522,418AUD, 2019 -- 2023
2014
Improving peritoneal dialysis practices and outcomes in Australia
Badve, Sunil
National Health and Medical Research Council (NHMRC) (ID: 1061235), $489,750AUD, 2014 -- 2017
2013
Evaluation of In Vitro Companion Diagnostic Monoclonal Antibodies for Use in a St
Badve, Sunil S and HORVATH, CHRISTOPHER
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R41CA174035-01S1), $149,799USD, 09/25/2012 -- 03/31/2014
2012
Evaluation of In Vitro Companion Diagnostic Monoclonal Antibodies for Use in a St
Badve, Sunil S and HORVATH, CHRISTOPHER
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R41CA174035-01), $267,215USD, 09/25/2012 -- 03/31/2014